You are here: Industry Insights > Covance

News List

LabCorp Launches New COVID-19 Clinical Trial Site contractpharma
June 02, 2020
To connect patients with US research trials; streamlining recruitment into studies to speed research.
Labcorp Accelerates Adoption of Decentralized Clinical Trials contractpharma
June 01, 2020
LabCorp’s drug development business, Covance, is expanding its technology ecosystem to accelerate the adoption of decentralized clinical trials, often referred to as hybrid and virtual clinical trials.
Covance Unveils New R&D Center in Shanghai contractpharma
September 19, 2019
LabCorp’s Covance Drug Development business celebrated the opening of its new R&D Center in Shanghai, China, which is now its largest facility in the Asia Pacific region.
Covance unveils new R&D center in Shanghai biospectrumasia
September 17, 2019
Inauguration Ceremony Highlights World-Class, Comprehensive Drug Development Capabilities and More Than Two Decades of Growth in China
Covance Launches Laboratory Data Management Functional Service contractpharma
September 06, 2019
LabCorp said that its Covance drug development business has launched a laboratory solution within its functional service provider (FSPx) offering.
Covance Launches Lab Solution within FSPx Offering contractpharma
August 30, 2019
Program comprises a clinical analytics service and clinical operations capabilities.
Covance recieves Frost and Sullivan Award biospectrumasia
October 23, 2018
Covance has recieved 2014 Frost Sullivan Asia Pacific CRO Growth Excellence Leadership AwardSingapore:Covance, a global
Covance Forms Immunology & Immunotoxicology Unit Focused on Biologic Drug Development biospace
March 12, 2018
LabCorp®announced today that its Covance Drug Development business has formed a global immunology and immunotoxicology (I&I) unit dedicated to the specific needs of biologic drug development.